On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump’s ...

The United States has seen progress in reducing certain cancer risks, as overall smoking rates remain on a decline.

First, the good news: The overall cancer death rate has been on a steady decline—as have smoking rates, with only 11% of ...

The National Institutes of Health’s sweeping cuts of grants that fund scientific research are inflicting pain almost ...

Dr. Drew shaped how we think about sex, addiction, and public health. His recent evolution to free-speech warrior says worlds ...

Shoham was one of dozens of hostages released from Gaza in February as part of a ceasefire agreement between Hamas and Israel ...

This piece won the OpiniUm Challenge, an academic research competition for the University of Miami’s graduate students to ...

The 19th reports on how the Trump administration's federal funding cuts are shutting down studies on Alzheimer's care, ...

As noted by the authors, HPV vaccination in this population presents special problems. By the time young males have "come out" to their parents or physicians, they have probably already initiated ...

Meanwhile it is also bringing some other high-profile new vaccines through late-stage development, including meningococcal vaccine Men ABCWY, which it thinks could become a £1 to £2 billion product.